Eph receptors and ephrin ligands: Important players in angiogenesis and tumor angiogenesis

Journal of Oncology

Volumn , Issue , 2010, Pages

  Mosch, Birgit ^a   Reissenweber, Bettina ^a   Neuber, Christin ^a   Pietzsch, Jens ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 BIS ANILINOPYRIMIDINE; 2,5 DIMETHYLPYRROLYL BENZOIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; BEVACIZUMAB; DASATINIB; EPHRIN; EPHRIN RECEPTOR; EPHRIN RECEPTOR A1; EPHRIN RECEPTOR A7; EPHRIN RECEPTOR B6; HYPOXIA INDUCIBLE FACTOR 1ALPHA; N SUBSTITUTED 3 AMINO 4 METHYLBENZAMIDE; RHO KINASE; SORAFENIB; SUNITINIB; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; CANCER COMBINATION CHEMOTHERAPY; CARCINOGENESIS; CELL ADHESION; CHRONIC MYELOID LEUKEMIA; COLORECTAL CANCER; DIMERIZATION; EMBRYO DEVELOPMENT; HUMAN; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MELANOMA; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOPHYSIOLOGY; PROSTATE CANCER; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 77951677126     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2010/135285     Document Type: Review

References (140)

1. Hirai H., Maru Y., Hagiwara K., Nishida J., Takaku F., A novel putative tyrosine kinase receptor encoded by the eph gene Science 1987 238 4834 1717 1720
2. Brantley-Sieders D., Schmidt S., Parker M., Chen J., Eph receptor tyrosine kinases in tumor and tumor microenvironment Current Pharmaceutical Design 2004 10 27 3431 3442 (Pubitemid 39276627)
3. Zhou R., The Eph family receptors and ligands Pharmacology and Therapeutics 1998 77 3 151 181 (Pubitemid 28157319)
4. Kullander K., Klein R., Mechanisms and functions of Eph and ephrin signalling Nature Reviews Molecular Cell Biology 2002 3 7 475 486 (Pubitemid 34733429)
5. Himanen J.-P., Chumley M. J., Lackmann M., Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling Nature Neuroscience 2004 7 5 501 509 (Pubitemid 38544589)
6. Pasquale E. B., Eph-ephrin promiscuity is now crystal clear Nature Neuroscience 2004 7 5 417 418
7. Surawska H., Ma P. C., Salgia R., The role of ephrins and Eph receptors in cancer Cytokine and Growth Factor Reviews 2004 15 6 419 433 (Pubitemid 39550453)
8. Stein E., Lane A. A., Cerretti D. P., Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses Genes and Development 1998 12 5 667 678 (Pubitemid 28134299)
9. Alford S. C., Bazowski J., Lorimer H., Elowe S., Howard P. L., Tissue transglutaminase clusters soluble A-type ephrins into functionally active high molecular weight oligomers Experimental Cell Research 2007 313 20 4170 4179 (Pubitemid 350087045)
10. Wykosky J., Palma E., Gibo D. M., Ringler S., Turner C. P., Debinski W., Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor Oncogene 2008 27 58 7260 7273
11. Brckner K., Pasquale E. B., Klein R., Tyrosine phosphorylation of transmembrane ligands for Eph receptors Science 1997 275 5306 1640 1643
12. Holland S. J., Gale N. W., Mbamalu G., Yancopoulos G. D., Henkemeyer M., Pawson T., Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands Nature 1996 383 6602 722 725
13. Pasquale E. B., Eph-ephrin bidirectional signaling in physiology and disease Cell 2008 133 1 38 52
14. Binns K. L., Taylor P. P., Sicheri F., Pawson T., Holland S. J., Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors Molecular and Cellular Biology 2000 20 13 4791 4805
15. Zisch A. H., Pazzagli C., Freeman A. L., Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses Oncogene 2000 19 2 177 187
16. Arvanitis D., Davy A., Eph/ephrin signaling: networks Genes and Development 2008 22 4 416 429
17. Holder N., Klein R., Eph receptors and ephrins: effectors of morphogenesis Development 1999 126 10 2033 2044
18. Oates A. C., Lackmann M., Power M.-A., An early developmental role for Eph-ephrin interaction during vertebrate gastrulation Mechanisms of Development 1999 83 1-2 77 94
19. Janes P. W., Adikari S., Lackmann M., Eph/ephrin signalling and function in oncogenesis: lessons from embryonic development Current Cancer Drug Targets 2008 8 6 473 489
20. Klein R., Neural development: bidirectional signals establish boundaries Current Biology 1999 9 18 R691 R694
21. Mellitzer G., Xu Q., Wilkinson D. G., Eph receptors and ephrins restrict cell intermingling and communication Nature 1999 400 6739 77 81
22. Dottori M., Hartley L., Galea M., EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract Proceedings of the National Academy of Sciences of the United States of America 1998 95 22 13248 13253
23. Kullander K., Mather N. K., Diella F., Dottori M., Boyd A. W., Klein R., Kinase-dependent and kinase-independent functions of EphA4 receptors in major axon tract formation in vivo Neuron 2001 29 1 73 84
24. Hornberger M. R., Dtting D., Ciossek T., Modulation of EphA receptor function by coexpressed EphrinA ligands on retinal ganglion cell axons Neuron 1999 22 4 731 742
25. Birgbauer E., Cowan C. A., Sretavan D. W., Henkemeyer M., Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina Development 2000 127 6 1231 1241
26. Chen Y., Fu A. K. Y., Ip N. Y., Bidirectional signaling of ErbB and Eph receptors at synapses Neuron Glia Biology 2008 4 3 211 221
27. Klein R., Bidirectional modulation of synaptic functions by Eph/ephrin signaling Nature Neuroscience 2009 12 1 15 20
28. Henderson J. T., Georgiou J., Jia Z., The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function Neuron 2001 32 6 1041 1056
29. Dodelet V. C., Pasquale E. B., Eph receptors and ephrin ligands: embryogenesis to tumorigenesis Oncogene 2000 19 49 5614 5619
30. Frieden L., Chen J., Tang C. K., Ephrins and Eph receptors in cancer Recent Progress in Cancer Research 2007 11 35
31. Wimmer-Kleikamp S. H., Lackmann M., Eph-modulated cell morphology, adhesion and motility in carcinogenesis IUBMB Life 2005 57 6 421 431
32. Dong Y., Wang J., Sheng Z., Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis Modern Pathology 2009 22 1 151 160
33. Guan M., Xu C., Zhang F., Ye C., Aberrant methylation of EphA7 in human prostate cancer and its relation to clinicopathologic features International Journal of Cancer 2009 124 1 88 94
34. Hafner C., Bataille F., Meyer S., Loss of EphB6 expression in metastatic melanoma International Journal of Oncology 2003 23 6 1553 1559
35. Maru Y., Hirai H., Takaku F., Overexpression confers an oncogenic potential upon the eph gene Oncogene 1990 5 3 445 447
36. Miao H., Wei B.-R., Peehl D. M., Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway Nature Cell Biology 2001 3 5 527 530 (Pubitemid 32422092)
37. Miao H., Burnett E., Kinch M., Simon E., Wang B., Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation Nature Cell Biology 2000 2 2 62 69
38. Zou J. X., Wang B., Kalo M. S., Zisch A. H., Pasquale E. B., Ruoslahti E., An Eph receptor regulates integrin activity through R-Ras Proceedings of the National Academy of Sciences of the United States of America 1999 96 24 13813 13818
39. Gallouzi I.-E., Brennan C. M., Stenberg M. G., HuR binding to cytoplasmic mRNA is perturbed by heat shock Proceedings of the National Academy of Sciences of the United States of America 2000 97 7 3073 3078
40. Winter J., Roepcke S., Krause S., Comparative 3′ UTR analysis allows identification of regulatory clusters that drive Eph/ephrin expression in cancer cell lines PLoS ONE 2008 3 7, article e2780
41. Chiu S.-T., Chang K.-J., Ting C.-H., Shen H.-C., Li H., Hsieh F.-J., Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells Carcinogenesis 2009 30 9 1475 1486
42. Cortina C., Palomo-Ponce S., Iglesias M., EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells Nature Genetics 2007 39 11 1376 1383 (Pubitemid 350034995)
43. Zantek N. D., Azimi M., Fedor-Chaiken M., Wang B., Brackenbury R., Kinch M. S., E-cadherin regulates the function of the EphA2 receptor tyrosine kinase Cell Growth and Differentiation 1999 10 9 629 638 (Pubitemid 29455727)
44. Lawrenson I. D., Wimmer-Kleikamp S. H., Lock P., Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling Journal of Cell Science 2002 115 5 1059 1072 (Pubitemid 34257389)
45. Wahl S., Barth H., Ciossek T., Aktories K., Mueller B. K., Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase Journal of Cell Biology 2000 149 2 263 270 (Pubitemid 30227145)
46. Clifford N., Smith L. M., Powell J., Gattenlhner S., Marx A., OConnor R., The EphA3 receptor is expressed in a subset of rhabdomyosarcoma cell lines and suppresses cell adhesion and migration Journal of Cellular Biochemistry 2008 105 5 1250 1259
47. Feng Y.-X., Zhao J.-S., Li J.-J., Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF- B signaling pathway Hepatology 2010 51 2 535 544
48. Holen H. L., Shadidi M., Narvhus K., Kjsnes O., Tierens A., Aasheim H.-C., Signaling through ephrin-A ligand leads to activation of Src-family kinases, Akt phosphorylation, and inhibition of antigen receptor-induced apoptosis Journal of Leukocyte Biology 2008 84 4 1183 1191
49. Balakrishnan A., Bleeker F. E., Lamba S., Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma Cancer Research 2007 67 8 3545 3550 (Pubitemid 46762135)
50. Lin J., Gan C. M., Zhang X., A multidimensional analysis of genes mutated in breast and colorectal cancers Genome Research 2007 17 9 1304 1318 (Pubitemid 47360905)
51. Hanahan D., Folkman J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 1996 86 3 353 364 (Pubitemid 26272076)
52. Iruela-Arispe M. L., Dvorak H. F., Angiogenesis: a dynamic balance of stimulators and inhibitors Thrombosis and Haemostasis 1997 78 1 672 677
53. Hanahan D., Weinberg R. A., The hallmarks of cancer Cell 2000 100 1 57 70 (Pubitemid 30046295)
54. Yancopoulos G. D., Davis S., Gale N. W., Rudge J. S., Wiegand S. J., Holash J., Vascular-specific growth factors and blood vessel formation Nature 2000 407 6801 242 248
55. Brantley-Sieders D. M., Chen J., Eph receptor tyrosine kinases in angiogenesis: from development to disease Angiogenesis 2004 7 1 17 28 (Pubitemid 39127767)
56. Kim Y. H., Hu H., Guevara-Gallardo S., Lam M. T. Y., Fong S.-Y., Wang R. A., Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis Development 2008 135 22 3755 3764
57. Wang H. U., Chen Z.-F., Anderson D. J., Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4 Cell 1998 93 5 741 753
58. Gale N. W., Baluk P., Pan L., Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells Developmental Biology 2001 230 2 151 160 (Pubitemid 32171414)
59. Foo S. S., Turner C. J., Adams S., Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly Cell 2006 124 1 161 173
60. Oike Y., Ito Y., Hamada K., Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells Blood 2002 100 4 1326 1333
61. Fller T., Korff T., Kilian A., Dandekar G., Augustin H. G., Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells Journal of Cell Science 2003 116 12 2461 2470
62. Adams R. H., Diella F., Hennig S., Helmbacher F., Deutsch U., Klein R., The cytoplasmic domain of the ligand EphrinB2 is required for vascular morphogenesis but not cranial neural crest migration Cell 2001 104 1 57 69
63. Salvucci O., Maric D., Economopoulou M., EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures Blood 2009 114 8 1707 1716
64. Steinle J. J., Meininger C. J., Forough R., Wu G., Wu M. H., Granger H. J., Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway Journal of Biological Chemistry 2002 277 46 43830 43835
65. Adams R. H., Wilkinson G. A., Weiss C., Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis Genes and Development 1999 13 3 295 306
66. Cross J., Hemberger M., Lu Y., Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta Molecular and Cellular Endocrinology 2002 187 1-2 207 212
67. Egawa M., Yoshioka S., Higuchi T., Ephrin B1 is expressed on human luteinizing granulosa cells in corpora lutea of the early luteal phase: the possible involvement of the B class Eph-ephrin system during corpus luteum formation Journal of Clinical Endocrinology and Metabolism 2003 88 9 4384 4392
68. Huynh-Do U., Stein E., Lane A. A., Liu H., Cerretti D. P., Daniel T. O., Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through v3 and 51 integrins EMBO Journal 1999 18 8 2165 2173
69. McBride J. L., Ruiz J. C., Ephrin-A1 is expressed at sites of vascular development in the mouse Mechanisms of Development 1998 77 2 201 204
70. Cheng N., Brantley D. M., Liu H., Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis Molecular Cancer Research 2002 1 1 2 11
71. Cheng N., Brantley D. M., Chen J., The ephrins and Eph receptors in angiogenesis Cytokine and Growth Factor Reviews 2002 13 1 75 85
72. Brantley-Sieders D. M., Caughron J., Hicks D., Pozzi A., Ruiz J. C., Chen J., EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation Journal of Cell Science 2004 117 10 2037 2049
73. Daniel T. O., Stein E., Cerretti D. P., St. John P. L., Robert B., Abrahamson D. R., ELK and LERK-2 in developing kidney and microvascular endothelial assembly Kidney International 1996 50 57 S73 S81
74. Dobrzanski P., Hunter K., Jones-Bolin S., Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist Cancer Research 2004 64 3 910 919
75. Folkman J., Fighting cancer by attacking its blood supply Scientific American 1996 275 3 150 154
76. Ribatti D., Nico B., Crivellato E., Roccaro A. M., Vacca A., The history of the angiogenic switch concept Leukemia 2007 21 1 44 52
77. Liss C., Fekete M. J., Hasina R., Lingen M. W., Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma International Journal of Cancer 2002 100 3 283 289
78. Baird A., Ling N., Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response Biochemical and Biophysical Research Communications 1987 142 2 428 435
79. Homandberg G. A., Williams J. E., Grant D., Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth American Journal of Pathology 1985 120 3 327 332
80. Clapp C., Martial J. A., Guzman R. C., Rentier-Delrue F., Weiner R. I., The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis Endocrinology 1993 133 3 1292 1299
81. Ferrara N., Clapp C., Weiner R., The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells Endocrinology 1991 129 2 896 900
82. OReilly M. S., Holmgren L., Shing Y., Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 1994 79 2 315 328
83. Gupta S. K., Hassel T., Singh J. P., A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4 Proceedings of the National Academy of Sciences of the United States of America 1995 92 17 7799 7803
84. Tolsma S. S., Volpert O. V., Good D. J., Frazier W. A., Polverini P. J., Bouck N., Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity Journal of Cell Biology 1993 122 2 497 511
85. Nelson J., Allen W. E., Scott W. N., Murine epidermal growth factor (EGF) fragment (3342) inhibits both EGF- and laminin-dependent endothelial cell motility and angiogenesis Cancer Research 1995 55 17 3772 3776
86. Bissell M. J., Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch: a rose by any other name? American Journal of Pathology 1999 155 3 675 679
87. Maniotis A. J., Folberg R., Hess A., Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry American Journal of Pathology 1999 155 3 739 752
88. Hess A. R., Seftor E. A., Gardner L. M. G., Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2) Cancer Research 2001 61 8 3250 3255
89. Meyer S., Hafner C., Vogt T., Role of receptor tyrosine kinase in the angiogenesis Hautarzt 2002 53 9 629 642
90. Hess A. R., Seftor E. A., Gruman L. M., Kinch M. S., Seftor R. E. B., Hendrix M. J. C., VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry Cancer Biology and Therapy 2006 5 2 228 233
91. Nikolova Z., Djonov V., Zuercher G., Andres A.-C., Ziemiecki A., Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis Journal of Cell Science 1998 111 18 2741 2751
92. Kimura M., Kato Y., Sano D., Soluble form of ephrinB2 inhibits xenograft growth of squamous cell carcinoma of the Head and neck International Journal of Oncology 2009 34 2 321 327
93. Kumar S. R., Singh J., Xia G., Receptor tyrosine kinase EphB4 is a survival factor in breast cancer American Journal of Pathology 2006 169 1 279 293
94. Masood R., Ram Kumar S., Sinha U. K., EphB4 provides survival advantage to squamous cell carcinoma of the head and neck International Journal of Cancer 2006 119 6 1236 1248
95. Ogawa K., Pasqualini R., Lindberg R. A., Kain R., Freeman A. L., Pasquale E. B., The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization Oncogene 2000 19 52 6043 6052
96. Shao Z., Zhang W.-F., Chen X.-M., Shang Z.-J., Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome Oral Oncology 2008 44 12 1110 1117
97. Brantley D. M., Cheng N., Thompson E. J., Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo Oncogene 2002 21 46 7011 7026
98. Cheng N., Brantley D., Fang W. B., Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors Neoplasia 2003 5 5 445 456
99. Brantley-Sieders D. M., Fang W. B., Hicks D. J., Zhuang G., Shyr Y., Chen J., Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression FASEB Journal 2005 19 13 1884 1886
100. Lu C., Shahzad M. M. K., Wang H., EphA2 overexpression promotes ovarian cancer growth Cancer Biology and Therapy 2008 7 7 1098 1103
101. Noren N. K., Lu M., Freeman A. L., Koolpe M., Pasquale E. B., Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth Proceedings of the National Academy of Sciences of the United States of America 2004 101 15 5583 5588
102. Erber R., Eichelsbacher U., Powajbo V., EphB4 controls blood vascular morphogenesis during postnatal angiogenesis EMBO Journal 2006 25 3 628 641
103. Almog N., Ma L., Raychowdhury R., Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype Cancer Research 2009 69 3 836 844
104. Vihanto M. M., Plock J., Erni D., Frey B. M., Frey F. J., Huynh-Do U., Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin FASEB Journal 2005 19 12 1689 1691
105. Martin-Rendon E., Hale S. J. M., Ryan D., Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia Stem Cells 2007 25 4 1003 1012
106. Yamashita T., Ohneda K., Nagano M., Hypoxia-inducible transcription factor- 2 in endothelial cells regulates tumor neovascularization through activation of ephrin A1 Journal of Biological Chemistry 2008 283 27 18926 18936
107. Truog W. E., Xu D., Ekekezie I. I., Chronic hypoxia and rat lung development: analysis by morphometry and directed microarray Pediatric Research 2008 64 1 56 62
108. Marme D., The impact of anti-angiogenic agents on cancer therapy Journal of Cancer Research and Clinical Oncology 2003 129 11 607 620
109. Shibuya M., Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis Journal of Biochemistry and Molecular Biology 2008 41 4 278 286
110. Carles-Kinch K., Kilpatrick K. E., Stewart J. C., Kinch M. S., Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior Cancer Research 2002 62 10 2840 2847
111. Coffman K. T., Hu M., Carles-Kinch K., Differential EphA2 epitope display on normal versus malignant cells Cancer Research 2003 63 22 7907 7912
112. Mao W., Luis E., Ross S., EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer Cancer Research 2004 64 3 781 788
113. Vearing C., Lee F.-T., Wimmer-Kleikamp S., Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents Cancer Research 2005 65 15 6745 6754
114. Kertesz N., Krasnoperov V., Reddy R., The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth Blood 2006 107 6 2330 2338
115. Martiny-Baron G., Korff T., Schaffner F., Inhibition of tumor growth and angiogenesis by soluble EphB4 Neoplasia 2004 6 3 248 257
116. Scehnet J. S., Ley E. J., Krasnoperov V., The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade Blood 2009 113 1 254 263
117. Davies M. H., Zamora D. O., Smith J. R., Powers M. R., Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells Microvascular Research 2009 77 3 382 386
118. Zamora D. O., Davies M. H., Planck S. R., Rosenbaum J. T., Powers M. R., Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy Investigative Ophthalmology and Visual Science 2005 46 6 2175 2182
119. Gobin A. M., Moon J. J., West J. L., Ephrin A1-targeted nanoshells for photothermal ablation of prostate cancer cells International Journal of Nanomedicine 2008 3 3 351 358
120. Chrencik J. E., Brooun A., Recht M. I., Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity Structure 2006 14 2 321 330
121. Chrencik J. E., Brooun A., Recht M. I., Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition Journal of Biological Chemistry 2007 282 50 36505 36513
122. Koolpe M., Burgess R., Dail M., Pasquale E. B., EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity Journal of Biological Chemistry 2005 280 17 17301 17311
123. Koolpe M., Dail M., Pasquale E. B., An ephrin mimetic peptide that selectively targets the EphA2 receptor Journal of Biological Chemistry 2002 277 49 46974 46979
124. Yamaguchi S., Tatsumi T., Takehara T., Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines Cancer 2007 110 7 1469 1477
125. Bardelle C., Coleman T., Cross D., Inhibitors of the tyrosine kinase EphB4. Part 2: structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines Bioorganic and Medicinal Chemistry Letters 2008 18 21 5717 5721
126. Bardelle C., Cross D., Davenport S., Inhibitors of the tyrosine kinase EphB4. Part 1: structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines Bioorganic and Medicinal Chemistry Letters 2008 18 9 2776 2780
127. Noberini R., Koolpe M., Peddibhotla S., Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors Journal of Biological Chemistry 2008 283 43 29461 29472
128. Choi Y., Syeda F., Walker J. R., Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors Bioorganic and Medicinal Chemistry Letters 2009 19 15 4467 4470
129. Keam S. J., Dasatinib: in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia BioDrugs 2008 22 1 59 69
130. Buettner R., Mesa T., Vultur A., Lee F., Jove R., Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells Molecular Cancer Research 2008 6 11 1766 1774
131. Pichot C. S., Hartig S. M., Xia L., Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells British Journal of Cancer 2009 101 1 38 47
132. Konecny G. E., Glas R., Dering J., Activity of the multikinase inhibitor dasatinib against ovarian cancer cells British Journal of Cancer 2009 101 10 1699 1708
133. Chang Q., Jorgensen C., Pawson T., Hedley D. W., Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer British Journal of Cancer 2008 99 7 1074 1082
134. Zhou Z., Yuan X., Li Z., RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cells Surgical Neurology 2008 70 6 562 568
135. Vaught D., Brantley-Sieders D. M., Chen J., Eph receptors in breast cancer: roles in tumor promotion and tumor suppression Breast Cancer Research 2008 10 6 217
136. Noren N. K., Pasquale E. B., Paradoxes of the EphB4 receptor in cancer Cancer Research 2007 67 9 3994 3997
137. Wykosky J., Debinski W., The EphA2 receptor and EphrinA1 ligand in solid tumors: function and therapeutic targeting Molecular Cancer Research 2008 6 12 1795 1806
138. Kiewlich D., Zhang J., Gross C., Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth Neoplasia 2006 8 1 18 30
139. Brantley-Sieders D. M., Zhuang G., Hicks D., The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling Journal of Clinical Investigation 2008 118 1 64 78
140. Chen J., Zhuang G., Frieden L., Debinski W., Eph receptors and ephrins in cancer: common themes and controversies Cancer Research 2008 68 24 10031 10033